|
W3C
Reset Setting Change font size to lower sizeChange font size to original sizeChange font size to large size
    T
    T
    T
    T
    T
    T

TOPICS

Results for Topics : "Fertility"


Download Attachment
:
 3
 Downloads
Choosing not to mother? childfree and childless women and their contribution to fertility decline in Malaysia
Item Type: Conference or Workshop Item
Author: 
Abdul Razak, Ahmad Rasyidee and
Khairitszi Mamat, Suszma and
George Albert, Wanda Kiyah and
Bali, Norafifah and
Ayub, Norzihan and
Sombuling, Agnis and
Yusof, Husmiati and
Author: 
Editor: 
Year:  16/05/2026
Abstract:  In Malaysia, the Total Fertility Rate (TFR) has declined to 1.6 births per woman (2024), which is below the replacement level of 2.1. Over the past decade, the world has experienced significant demographic and cultural changes, particularly in family structures, including declining fertility rates and shifting norms around marriage. Globally, there is a growing trend of individuals choosing not to have children – not due to infertility or delayed marriage, but based on personal choice. This study aims to explore the contribution of childfree and childless women to fertility decline in Malaysia. The findings show that childfree and childless women experience non-motherhood differently, with childfree women often associating it with autonomy and emotional fulfilment, while childless women experience greater emotional vulnerability and social pressure.
 
 
:
 3
 All Downloads


Download Attachment
:
 15
 Downloads
Clinical evaluation of Buserelin, a GnRH analogue in the management of moderate to severe pelvic endometriosis
Item Type: Article
Author: 
M.T.M., Ismail and
H.A., Wadood and
M., Azhar and
Arshat, Hamid and
Author: 
Editor: 
Year:  00/12/1990
Abstract:  A local study, a part of a multinasional and multicenter study on the efficacy and safety of Buserelin was carried out for the treatment of pelvic endometriosis using a standard protocol. 20 women diagnosed to have moderate to severe endometriosis by laparoscopy were recruited. The women were given 900 micrograms Buserelin acetate daily by intranasal spray for a fixed period of 6 months. Baseline hormonal and biochemical parameters were taken prior to treatment and the parameters were repeated during each follow-up at weekly and monthly intervals. In addition, changes in symptoms were monitored. A second look laparoscopy was performed at completion of therapy and patients were followed up for a further 6 months. There was 100 percent suppression of oestradiol levels during the 6 months treatment period. An improvement of implants according to AFS classification occured in all patients. One patient discontinued because of side effects. Restoration of cycles after completion of therapy occured within 7 weeks. There were 7 pregnancies (64%) in the first 6 months after treatment for those wanting pregnancies. During therapy, dysmenorrhoea, pelvic pain and dyspareunia improved considerably. Buserelin was proven to be effective in the management of pelvic endometriosis and is well tolerated and safe.
 
 
:
 15
 All Downloads